UFRANKLIN LAKES, NJ - kunye noTUCSON, Ariz. BD (Becton, Dickinson kunye neNkampani) (NYSE: BDX), inkampani ehamba phambili yezobuchwepheshe bezonyango zehlabathi, kunye ne-Accelerate Diagnostics, Inc. (NASDAQ: AXDX) i-innovator ye-in-vitro diagnostics ngokukhawuleza. kwi-Microbiology, namhlanje ibhengeze isivumelwano sentsebenziswano yorhwebo kwihlabathi jikelele apho i-BD iya kubonelela ngesisombululo esikhawulezayo sovavanyo lwe-Accelerate yokuxhathisa amayeza okubulala iintsholongwane kunye nokunikezela ngeziphumo ngeeyure, xa kuthelekiswa nosuku olunye ukuya kwezimbini ngeendlela ezithile zaselabhoratri zesintu.
Ngaphantsi kwesivumelwano, i-BD iya kuthengisa kwaye ithengise inkqubo ye-Accelerate Pheno® kunye ne-Accelerate Arc ™ imodyuli kunye nezixhobo zokuvavanya ezihambelanayo ngothungelwano lwayo lwentengiso yehlabathi kwimimandla apho iimveliso zinemvume yokulawula okanye ukubhaliswa.Ezi zisombululo zincedisana nepotifoliyo ye-BD ekhoyo yeClinical Microbiology kwaye iqhubela phambili injongo ekwabelwana ngayo yazo zombini iinkampani ukujongana nosongelo lwehlabathi lokunganyangeki ngamachiza.
"Xa isigulane sigula kakhulu, yonke iminithi ibalulekile," kusho uBrooke Story, umongameli we-Integrated Diagnostic Solutions for BD.“Uvavanyo olukhawulezileyo lunokuqinisekisa ngokukhawuleza ukuba iyeza lokubulala iintsholongwane kufuneka lisetyenziswe kunyango, kwaye ukuba kunjalo, yeyiphi.Ngokusebenzisana kwethu ne-Accelerate Diagnostics, sinokunceda oogqirha ngokukhawuleza, ngokufanelekileyo nangempumelelo ukunyanga izigulana, nto leyo enokukhokelela ekuthotyweni kweendleko zokhathalelo lwempilo kwaye incede ukucothisa ukusasazeka kwe-antimicrobial resistance. "
I-Accelerate PhenoTest® BC kit luvavanyo lokuqala olucinywe yi-US Food and Drug Administration enokuthi ibonelele ngokukhawuleza ukuchongwa kunye ne-phenotypic antibiotics susceptibility iziphumo kwiiyure ezithe ngqo kwiinkcubeko ezilungileyo zegazi.Uphononongo lwangaphandle lwakutsha nje lubonisa ukuba esi sicombululo sibonelela ngeziphumo iintsuku enye ukuya kwezimbini ngokukhawuleza kuneendlela zaselabhoratri zesintu, ezinokuthi zibandakanye ukulima iisampulu iiyure ezili-18 ukuya kwezingama-24, kwaye emva koko zenze uvavanyo lokuchaphazeleka olunokuthatha iiyure ezisibhozo ukuya kwezingama-24 ukuphumela.Oku kwenza ukuba oogqirha bakwazi ukukhetha i-antibiotics kunye nedosi ethile kwisigulana ngasinye, kwiintsuku ezingaphambili.Kuqiniswe kakuhle kuncwadi oluphononongwe ngontanga ukuba ukuphuculwa kwexesha lonyango olulungileyo kuluncedo kwiziphumo zesigulane kunye nokusebenza kwezibhedlele.
Imodyuli ye-Accelerate Arc™ yinkqubo elula yokulayisha kunye nokuhamba esusa imfuno ye-subculture ye-ID ye-MALDI kunye nesidingo sezandla ezinde-ngexesha ngokwenza ngokuzenzekelayo ukuhamba komsebenzi we-MALDI ID.Okwangoku i-US, i-CE-IVDR kunye ne-UKCA ebhaliswe kwiinkcubeko zegazi ezilungileyo.
"Ngesiseko esikhulu sabathengi esifakelweyo se-BD kwiinkqubo ze-microbiology yeklinikhi, le ntsebenziswano ikwandisa kakhulu ukufikelela kwethu kwezorhwebo kwihlabathi kwaye ibonelela ngeendlela ezininzi zokunyusa ukungena kwethu kwintengiso ngePheno kunye ne-Arc ukufikelela koogqirha kunye nezigulana," utshilo uJack Phillips, umongameli kunye ne-CEO ye-Accelerate. Ukuxilongwa."Ngaphaya kwezibonelelo zeklinikhi kunye nezorhwebo kwangoko, siyavuya malunga nethuba lokusebenzisana ne-BD njengenkokeli yexesha elide kwi-microbiology yeklinikhi."
Ixesha lokuposa: Sep-01-2022